ArticleBMC medical imaging2025
A novel MRI-based deep learning imaging biomarker for comprehensive assessment of the lenticulostriate artery-neural complex.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesTo develop a deep learning network for extracting features from the blood-supplying regions of the lenticulostriate artery (LSA) and to establish these features as an imaging biomarker for the comprehensive assessment of the lenticulostriate artery-neural complex (LNC). MATERIALS AND
methodsAutomatic segmentation of brain regions on T1-weighted images was performed, followed by the development of the ResNet18 framework to extract and visualize deep learning features from three regions of interest (ROIs). The root mean squared error (RMSE) was then used to assess the correlation between these features and fractional anisotropy (FA) values from diffusion tensor imaging (DTI) and cerebral blood flow (CBF) values from arterial spin labeling (ASL). The correlation of these features with LSA root numbers and three disease categories was further validated using fine-tuning classification (Task1 and Task2).
resultsSeventy-nine patients were enrolled and classified into three groups. No significant differences were found in the number of LSA roots between the right and left hemispheres, nor in the FA and CBF values of the ROIs. The RMSE loss, relative to the mean FA and CBF values across different ROI inputs, ranged from 0.154 to 0.213%. The model's accuracy in Task1 and Task2 fine-tuning classification reached 100%.
conclusionsDeep learning features extracted from the basal ganglia nuclei effectively reflect cerebrovascular and neurological functions and reveal the damage status of the LSA. This approach holds promise as a novel imaging biomarker for the comprehensive assessment of the LNC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.